STC
ACOR

SEI Trust Company’s Acorda Therapeutics ACOR Stock Holding History

SEI Trust Company’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-238
Closed -$836K – 1692
2013
Q4 		$836K Buy
238
+37
+18% +$144K 0.01% 1008
2013
Q3 		$827K Buy
201
+155
+337% +$668K 0.01% 937
2013
Q2 		$181K Buy
+46
New +$189K ﹤0.01% 1188

Other funds holding ACOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SEI Trust Company's ACOR Position: Q1 2014 in Review

SEI Trust Company sold out of Acorda Therapeutics (ACOR) in Q1 2014, closing a stake of 238 shares — an estimated $836K sold.

SEI Trust Company first reported a position in ACOR in Q2 2013 and held it in 3 quarters. The position peaked at $836K in Q4 2013. 152 funds tracked by Wall St. Rank hold ACOR as of Q1 2014.

  • SEI Trust Company reported no remaining Acorda Therapeutics position as of Q1 2014 after selling out during the quarter.
  • SEI Trust Company sold 238 Acorda Therapeutics shares in Q1 2014, an estimated $836K.
  • SEI Trust Company first reported a position in Acorda Therapeutics in Q2 2013 and held it in 3 quarters.
  • SEI Trust Company's Acorda Therapeutics position peaked at $836K in Q4 2013.
  • 152 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q1 2014.

Based on SEI Trust Company's 13F filing for Q1 2014, filed 28 Apr 2014.